Literature DB >> 8831434

Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.

M Davidson1, P Harvey, K A Welsh, P Powchik, K M Putnam, R C Mohs.   

Abstract

OBJECTIVE: Previous studies have suggested that geriatric inpatients with chronic schizophrenia manifest profound cognitive impairments. This study investigated how these cognitive impairments resemble those seen in degenerative dementing conditions.
METHOD: The neuropsychological battery of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), widely used to characterize the cognitive deficits of patients with Alzheimer's disease, was used to compare patterns of cognitive impairment in 66 triads of subjects consisting of one elderly patient with Alzheimer's disease, one elderly, institutionalized patient with chronic schizophrenia, and one elderly, cognitively normal comparison subject who were matched on age, gender, and education. For some analyses, the two groups of patients were divided into subgroups according to the degree of their cognitive impairment (mild, moderate, or severe) as determined by their scores on the Mini-Mental State examination.
RESULTS: Relative to the comparison subjects, both groups of patients showed cognitive deficits on each of the neuropsychological measures. The schizophrenic patients performed worse than the patients with Alzheimer's disease on tests of naming and constructional praxis but were less impaired on the test of delayed word recall. These differences were consistent across all levels of severity of globally measured cognitive impairment.
CONCLUSIONS: Consistent with earlier findings from postmortem studies, these findings suggest that major differences exist in the neurobiologic mechanisms responsible for cognitive impairment in schizophrenia and Alzheimer's disease. Effects directly attributable to social and environmental differences between these two groups of patients may also play a role.

Entities:  

Mesh:

Year:  1996        PMID: 8831434     DOI: 10.1176/ajp.153.10.1274

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

1.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Authors:  Buranee Kanchanatawan; Solaphat Hemrungrojn; Supaksorn Thika; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-09-05       Impact factor: 5.590

2.  A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia.

Authors:  Mario Fioravanti; Olimpia Carlone; Barbara Vitale; Maria Elena Cinti; Linda Clare
Journal:  Neuropsychol Rev       Date:  2005-06       Impact factor: 7.444

3.  Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.

Authors:  V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

4.  Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life.

Authors:  Christina Ting; Tarek K Rajji; Zahinoor Ismail; David F Tang-Wai; Nina Apanasiewicz; Dielle Miranda; David Mamo; Benoit H Mulsant
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

Review 5.  Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.

Authors:  Joseph I Friedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

6.  A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia.

Authors:  Serge A Mitelman; Adam M Brickman; Lina Shihabuddin; Randall E Newmark; Erin A Hazlett; M Mehmet Haznedar; Monte S Buchsbaum
Journal:  Neuroimage       Date:  2007-05-24       Impact factor: 6.556

7.  DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia.

Authors:  Ned Buttner; Sujoy Bhattacharyya; John Walsh; Francine M Benes
Journal:  Schizophr Res       Date:  2007-04-17       Impact factor: 4.939

8.  Postmortem studies in schizophrenia.

Authors:  P J Harrison
Journal:  Dialogues Clin Neurosci       Date:  2000-12       Impact factor: 5.986

9.  Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment.

Authors:  Buranee Kanchanatawan; Sookjaroen Tangwongchai; Thitiporn Supasitthumrong; Sira Sriswasdi; Michael Maes
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

Review 10.  The myth of schizophrenia as a progressive brain disease.

Authors:  Robert B Zipursky; Thomas J Reilly; Robin M Murray
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.